100 likes | 261 Views
MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT. Policy Cures. Innovative ideas and accurate analysis to accelerate development and uptake of new drugs, vaccines, diagnostics and other products for neglected diseases of the developing world. G-FINDER.
E N D
MALARIA AND NEGLECTED TROPICAL DISEASES (NTDs): FINDINGS FROM THE 2012 G-FINDER REPORT
Policy Cures Innovative ideas and accurate analysis to accelerate development and uptake of new drugs, vaccines, diagnostics and other products for neglected diseases of the developing world
G-FINDER • Annual survey of global investment into R&D of new neglected disease products • Neutral, comparable, comprehensive analysis • Commissioned by the Bill & Melinda Gates Foundation • 31 neglected diseases • 134 product areas • All R&D stages
Malaria – overall funding $84.9m higher in 2011 than in 2007
Malaria – by product area • Vaccines,diagnostics and vector control R&D ↑ • Drug R&D → • Basic research ↑
Who funds malaria R&D? Gates Foundation 26.3% US NIH 20.7% Industry (aggregate) 18.7% 66%
NTDs WHO classification G-FINDER HIV/AIDS Malaria TB Diarrhoeal diseases Bacterial pneumonia & meningitis Salmonella infections Rheumatic fever Buruli ulcer Dengue Kinetoplastids (Chagas, HAT, leishmaniasis) Helminths(lymphatic filariasis, STHs, cysticercosis, onchocerciasis, schistosomiasis) Leprosy Trachoma Guinea worm disease Echinococcosis Foodborne trematode infections Rabies Yaws 65% 50%
NTDs – leprosy, Buruli ulcer and trachoma $9.6m $5.8m $7.4m
Download the full report at www.policycures.org/g-finder2012.html